You are here Home Vaccines Vaccines Flucelvax Details for Flucelvax (influenza) vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 23 April 2019. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor Seqirus Administration route Intramuscular injection Vaccine group All people aged ≥6 months Description: Registered for use in people aged ≥6 months. Trivalent inactivated influenza vaccine (surface antigen, prepared in cell culture) Each 0.5 mL monodose pre-filled syringe contains: 15 µg haemagglutinin of each of the 3 recommended influenza virus strains May contain traces of: propiolactone cetyltrimethylammonium bromide polysorbate 80 For Product Information and Consumer Medicine Information about Flucelvax visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Page history Last updated 13 March 2026 Last reviewed 13 March 2026 Related diseases Influenza (flu) Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
